Real-World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated With Inotuzumab Ozogamicin
Talha Badar, Anikó Szabó, Martha Wadleigh, Michaela Liedtke, Shukaib Arslan, Caitlin Siebenaller, Ibrahim Aldoss, Elizabeth Schultz, Mehrdad Hefazi, Mark R. Litzow, Eric Kuo, Amy Wang, Emily Curran, Rory M. Shallis, Nikolai A. Podoltsev, Suresh Kumar Balasubramanian, Jay Yang, Ryan J. Mattison, Madelyn Burkart, Shira Dinner, Anjali S. Advani, Ehab Atallah
Topics & Concepts
MedicineInternal medicineHazard ratioCalicheamicinRefractory (planetary science)GastroenterologyAdverse effectHematopoietic stem cell transplantationMinimal residual diseaseTransplantationSurgerySalvage therapyChemotherapyLeukemiaConfidence intervalPhysicsMyeloid leukemiaAstrobiologyChronic Lymphocytic Leukemia ResearchAcute Lymphoblastic Leukemia researchCAR-T cell therapy research